Organization | Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Fundación Canaria Rafael Clavijo para la Investigación Biomédica Report issue

Foundation Phase 2 Phase 4

Founded: Spain

Organization Overview

First Clinical Trial

2007

NCT01078818

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Alberto Domínguez Rodríguez | Armando Torres Ramírez

Active Ingredients

Drugs in Phase 4 Trials (10)

cetearyl alcohol (1 trial)

cyclosporine (sandimmune) (1 trial)

ferrous fumarate (1 trial)

iron sucrose (venofer) (1 trial)

midazolam (versed) (1 trial)

morphine (1 trial)

polyethylene glycol (1 trial)

prednisone (meticorten) (1 trial)

tacrolimus (prograf) (1 trial)

vitamin c (1 trial)

Drugs in Phase 2 Trials (1)

melatonin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Edema (Phase 4)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

Pulmonary Edema (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 11